Published on Management Sciences for Health (https://www.msh.

org)
Home > MDS-3: Managing Access to Medicines and Health Technologies

Publication

File:
Download the complete MDS-3 publication [1]

Managing Drug Supply (MDS) is the leading reference on how to manage essential medicines
in developing countries. MDS was originally published in 1982. It was revised in 1997 with
over 10,000 copies distributed in over 60 countries worldwide. The third edition, MDS-3:
Managing Access to Medicines and other Health Technologies reflects the dramatic changes
in politics and public health priorities, advances in science and medicine, greater focus on
health care systems, increased donor funding, and the advent of information technology that
have profoundly affected access to essential medicines over the past 14 years. The revised
edition has many new areas that have been added or enhanced, including six new chapters:

Intellectual Property and Access to Medicines

Traditional and Complementary Medicines Policy
Pharmaceutical Pricing Policy
Pharmaceutical Benefits in Insurance Programs
Drug Seller Initiatives
Pharmacovigilance

In addition to being able to download individual chapters, MDS-3 will soon be available on CD-
ROM and flash drive. To download individual chapters, click on the links below under each
section.

The paperback version of MDS-3 is available at a 40% discount to individuals and

organizations in low- and middle-income countries. For information on ordering copies of the
book, contact the publisher through its website [2].
CONTENTS
Front Matter, including Contributors, Reviewers, Contents, and How to Use MDS-3 [3]

Part I Policy and Economic Issues

Policy and Legal Framework

1. Toward Sustainable Access to Medicines [4]

2. Historical and Institutional Perspectives [5]
3. Intellectual Property and Access to Medicines [6]
4. National Medicine Policy [7]
5. Traditional and Complementary Medicine Policy [8]
6. Pharmaceutical Legislation and Regulation [9]
7. Pharmaceutical Production Policy [10]
8. Pharmaceutical Supply Strategies [11]

Financing and Sustainability

9. Pharmaceutical Pricing Policy [12]

10. Economics for Pharmaceutical Management [13]
11. Pharmaceutical Financing Strategies [14]
12. Pharmaceutical Benefits in Insurance Programs [15]
13. Revolving Drug Funds and User Fees [16]
14. Global and Donor Financing [17]
15. Pharmaceutical Donations [18]

Part II Pharmaceutical Management

Selection

16. Managing Medicine Selection [19]

17. Treatment Guidelines and Formulary Manuals [20]

Procurement

18. Managing Procurement [21]

19. Quality Assurance for Pharmaceuticals [22]
20. Quantifying Pharmaceutical Requirements [23]
21. Managing the Tender Process [24]

Distribution

22. Managing Distribution [25]

23. Inventory Management [26]
24. Importation and Port Clearing [27]
25. Transport Management [28]
 26. Kit System Management [29]

Use

27. Managing for Rational Medicine Use [30]

28. Investigating Medicine Use [31]
29. Promoting Rational Prescribing [32]
30. Ensuring Good Dispensing Practices [33]
31. Community-Based Participation and Initiatives [34]
32. Drug Seller Initiatives [35]
33. Encouraging Appropriate Medicine Use by Consumers [36]
34. Medicine and Therapeutics Information [37]
35. Pharmacovigilance [38]

Part III Management Support Systems

Planning and Administration

36. Pharmaceutical Supply Systems Assessment [39]

37. Managing Pharmaceutical Programs [40]
38. Planning for Pharmaceutical Management [41]
39. Contracting for Pharmaceuticals and Services [42]
40. Analyzing and Controlling Pharmaceutical Expenditures [43]
41. Financial Planning and Management [44]
42. Planning and Building Storage Facilities [45]

Organization and Management

43. Security Management [46]

44. Medical Stores Management [47]
45. Hospital Pharmacy Management [48]
46. Pharmaceutical Management for Health Facilities [49]
47. Laboratory Services and Medical Supplies [50]

Information Management

48. Monitoring and Evaluation [51]

49. Pharmaceutical Management Information Systems [52]
50. Computers in Pharmaceutical Management [53]

Human Resources Management

51. Human Resources Management and Capacity Development [54]

52. Designing and Implementing Training Programs [55]

Index [56]
Source URL: https://www.msh.org/resources/mds-3-managing-access-to-medicines-and-health-
technologies

Links
[1] https://www.msh.org/sites/default/files/mds3-jan2014.pdf
[2] https://www.rienner.com/title/MDS_3_Managing_Access_to_Medicines_and_Health_Technologies
[3] https://www.msh.org/sites/msh.org/files/mds3-fm-revised-nov2012.pdf
[4] https://www.msh.org/sites/msh.org/files/mds3-ch01-sustainable-access-mar2012.pdf
[5] https://www.msh.org/sites/msh.org/files/mds3-ch02-historical-perspective-mar2012.pdf
[6] https://www.msh.org/sites/msh.org/files/mds3-ch03-intellectual-property-mar2012.pdf
[7] https://www.msh.org/sites/msh.org/files/mds3-ch04-national-medicine-plan-mar2012.pdf
[8] https://www.msh.org/sites/msh.org/files/mds3-ch05-traditional-medicines-mar2012.pdf
[9] https://www.msh.org/sites/msh.org/files/mds3-ch06-legislation-mar2012.pdf
[10] https://www.msh.org/sites/msh.org/files/mds3-ch07-production-policy-mar2012.pdf
[11] https://www.msh.org/sites/msh.org/files/mds3-ch08-supply-strategies-mar2012.pdf
[12] https://www.msh.org/sites/msh.org/files/mds3-ch09-pricing-policy-mar2012.pdf
[13] https://www.msh.org/sites/msh.org/files/mds3-ch10-pharmoeconomics-mar2012.pdf
[14] https://www.msh.org/sites/msh.org/files/mds3-ch11-financing-strategies-mar2012.pdf
[15] https://www.msh.org/sites/msh.org/files/mds3-ch12-insurance-mar2012.pdf
[16] https://www.msh.org/sites/msh.org/files/mds3-ch13-revolving-drug-funds-mar2012.pdf
[17] https://www.msh.org/sites/msh.org/files/mds3-ch14-donor-financing-mar2012.pdf
[18] https://www.msh.org/sites/msh.org/files/mds3-ch15-donations-mar2012.pdf
[19] https://www.msh.org/sites/msh.org/files/mds3-ch16-selection-mar2012.pdf
[20] https://www.msh.org/sites/msh.org/files/mds3-ch17-stgs-mar2012.pdf
[21] https://www.msh.org/sites/msh.org/files/mds3-ch18-procurement-mar2012.pdf
[22] https://www.msh.org/sites/msh.org/files/mds3-ch19-qualityassurance-mar2012.pdf
[23] https://www.msh.org/sites/msh.org/files/mds3-ch20-quantifying-mar2012.pdf
[24] https://www.msh.org/sites/msh.org/files/mds3-ch21-tenderprocess-mar2012.pdf
[25] https://www.msh.org/sites/msh.org/files/mds3-ch22-distribution-mar2012.pdf
[26] https://www.msh.org/sites/msh.org/files/mds3-ch23-inventorymgmt-mar2012.pdf
[27] https://www.msh.org/sites/msh.org/files/mds3-ch24-importation-mar2012.pdf
[28] https://www.msh.org/sites/msh.org/files/mds3-ch25-transportmgmt-mar2012.pdf
[29] https://www.msh.org/sites/msh.org/files/mds3-ch26-kitsystem-mar2012.pdf
[30] https://www.msh.org/sites/msh.org/files/mds3-ch27-rationaluse-mar2012.pdf
[31] https://www.msh.org/sites/msh.org/files/mds3-ch28-investigatinguse-mar2012.pdf
[32] https://www.msh.org/sites/msh.org/files/mds3-ch29-rationalprescribing-may2012.pdf
[33] https://www.msh.org/sites/msh.org/files/mds3-ch30-dispensing-mar2012.pdf
[34] https://www.msh.org/sites/msh.org/files/mds3-ch31-community-mar2012.pdf
[35] https://www.msh.org/sites/msh.org/files/mds3-ch32-sellerinitiatives-mar2012.pdf
[36] https://www.msh.org/sites/msh.org/files/mds3-ch33-consumeruse-mar2012.pdf
[37] https://www.msh.org/sites/msh.org/files/mds3-ch34-medicineinfo-mar2012.pdf
[38] https://www.msh.org/sites/msh.org/files/mds3-ch35-pharmacovigilance-mar2012.pdf
[39] https://www.msh.org/sites/msh.org/files/mds3-ch36-supplysystems-mar2012.pdf
[40] https://www.msh.org/sites/msh.org/files/mds3-ch37-managingprograms-mar2012.pdf
[41] https://www.msh.org/sites/msh.org/files/mds3-ch38-planningmgmt-mar2012.pdf
[42] https://www.msh.org/sites/msh.org/files/mds3-ch39-contracting-mar2012.pdf
[43] https://www.msh.org/sites/msh.org/files/mds3-ch40-expenditures-mar2012.pdf
[44] https://www.msh.org/sites/msh.org/files/mds3-ch41-financialplanning-mar2012.pdf
[45] https://www.msh.org/sites/msh.org/files/mds3-ch42-storage-mar2012.pdf
[46] https://www.msh.org/sites/msh.org/files/mds3-ch43-security-mgmt-mar2012.pdf
[47] https://www.msh.org/sites/msh.org/files/mds3-ch44-medicalstores-mar2012.pdf
[48] https://www.msh.org/sites/msh.org/files/mds3-ch45-hospitalpharmacymgmt-mar2012.pdf
[49] https://www.msh.org/sites/msh.org/files/mds3-ch46-facilitiespharmacymgmt-mar2012.pdf
[50] https://www.msh.org/sites/msh.org/files/mds3-ch47-labservices-mar2012.pdf
[51] https://www.msh.org/sites/msh.org/files/mds3-ch48-monitoring-mar2012.pdf
[52] https://www.msh.org/sites/msh.org/files/mds3-ch49-infosystems-mar2012.pdf
[53] https://www.msh.org/sites/msh.org/files/mds3-ch50-computers-mar2012.pdf
[54] https://www.msh.org/sites/msh.org/files/mds3-ch51-hrmgmt-mar2012.pdf
[55] https://www.msh.org/sites/msh.org/files/mds3-ch52-training-mar2012.pdf
[56] https://www.msh.org/sites/msh.org/files/mds3-index-may2012.pdf